Medical Condition News

RSS

Scientists identify two genes that regulate healthy fat levels in mice

Salk and Scripps Research Institute scientists, along with collaborators at the pharmaceutical company Lundbeck, identified two genes that can regulate levels of healthy fats, called FAHFAs, in mice.

4 May 2020

RA patients enrolled in Medicare plan face significant cost exposure on specialty drugs

After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study in the Journal of the American Medical Association Open finds.

4 May 2020

Individuals with high risk of cancer and CVD cannot be identified based on family history

Certain genetic changes, termed "pathogenic variants," substantially increase risk for cardiovascular disease and cancer--the leading causes of death--but testing to identify individual carriers is not part of current clinical practice.

4 May 2020

Certain scores can predict susceptibility of trauma patients to multiple infections

Trauma patients are at risk of developing multiple infections while in the hospital, but it's difficult to identify those who are especially susceptible.

4 May 2020

Study: Unique glucose-sensing neurons in the brain prevent severe hypoglycemia

Low blood sugar levels, known as hypoglycemia, can be a life-threatening situation, especially for people with type 1 diabetes who rely on intensive insulin therapy to prevent blood sugar from going too high.

4 May 2020

Study: Chronic exposure to inhaled nicotine alone leads to pulmonary hypertension

A study conducted by a team of researchers at LSU Health New Orleans has shown for the first time that chronic exposure to inhaled nicotine alone increases blood pressure (hypertension), in both the body's general circulation and in the lungs that can lead to pulmonary hypertension.

4 May 2020

Blood sugar control is key for people with type 2 diabetes and COVID-19

A study reported in the journal Cell Metabolism on April 30 adds to the evidence that people with type 2 diabetes (T2D) are at greater risk of a poor outcome should they become infected with the virus that causes COVID-19.

4 May 2020

Scripps professor receives Research Program Award for advancing RNA-targeting medicines

In recognition of his high-impact work advancing the field of RNA-targeting medicines, the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, has awarded Scripps Research Chemistry Professor Matthew Disney, PhD, a prestigious Research Program Award, to aid Disney's development of treatments for incurable diseases such as Alzheimer's, Parkinson's, ALS and frontotemporal dementia.

4 May 2020

Anti-malarial drug use for COVID-19 associated with increased risk of cardiac arrhythmias

Since the World Health Organization declared COVID-19 a Public Health Concern of Global Interest on January 30, more than one million have tested positive for the illness in the United States, and more than 62,000 have died.

3 May 2020

Research reveals mechanism underlying Parkinson's dyskinesia

Many people with Parkinson's disease eventually develop debilitating movements called dyskinesia, a side effect of their much-needed dopamine replacement medication.

3 May 2020

Cancer patients with COVID-19 more likely to die from the disease

People with cancer who develop COVID-19 are much more likely to die from the disease than those without cancer, according to physician-researchers at Montefiore Health System and Albert Einstein College of Medicine.

2 May 2020

AHA awards grants to 12 teams for fast-tracked heart and brain health research related to COVID-19

Less than a month after issuing a rapid response call for scientific research proposals for fast-tracked studies of the effects of COVID-19 on the body's cardiovascular and cerebrovascular systems, the American Heart Association has awarded $1.2 million in grants to teams at 12 institutions across the U.S. to begin this unprecedented work.

2 May 2020

Lipo-ImmunoTech receives grant to develop novel adoptive cell therapy technology for cancer

Lipo-ImmunoTech, LLC, a startup based in Charleston, South Carolina, recently received a Phase I Small Business Technology Transfer grant of just over $224,000 to continue to develop its novel adoptive cell therapy technology for cancer.

2 May 2020

Study finds Lin28 as promising therapeutic target for central nervous system injuries

Like power lines in an electrical grid, long wiry projections that grow outward from neurons - structures known as axons - form interconnected communication networks that run from the brain to all parts of the body.

2 May 2020

Study shows no association between prices and clinical benefit of cancer drugs

Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international UZH study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit.

2 May 2020

Combination of schizophrenia drug and radiation shows promise in treating glioblastoma

Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumors.

2 May 2020

Study finds racial differences in time from diagnosis to definitive surgery for melanoma

Black patients with one of the deadliest forms of skin cancer are likely to experience a longer delay from diagnosis to surgery than non-Hispanic white patients, according to a new study published in the Journal of the American Academy of Dermatology.

2 May 2020

New math model predicts clinical outcomes in cancer patients treated with immunotherapy

A group of our cancer and mathematics researchers at Houston Methodist have developed a clinically-applicable mathematical model to predict patient outcomes to cancer immunotherapy.

30 Apr 2020

COVID-19 lockdown affecting UK adult mental health

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) took a firmer hold on the UK, the government introduced a lockdown on March 24, 2020, in an all-out attempt to ‘flatten the curve’ of infections. While the number of deaths has fallen in response, a new study published in the journal medRxiv in April 2020 reports that the pandemic is also associated with increased anxiety and depression in UK adults experiencing isolation.

30 Apr 2020

Glasses to stop progression of myopia shown to work in multi-site trial

Glasses to stop myopia or nearsightedness in children have been shown to work in a multi-site trial of 256 children and will go on sale later this year outside the United States.

30 Apr 2020

Medical Condition News

Scientists identify two genes that regulate healthy fat levels in mice

RA patients enrolled in Medicare plan face significant cost exposure on specialty drugs

Individuals with high risk of cancer and CVD cannot be identified based on family history

Certain scores can predict susceptibility of trauma patients to multiple infections

Study: Unique glucose-sensing neurons in the brain prevent severe hypoglycemia

Study: Chronic exposure to inhaled nicotine alone leads to pulmonary hypertension

Blood sugar control is key for people with type 2 diabetes and COVID-19

Scripps professor receives Research Program Award for advancing RNA-targeting medicines

Anti-malarial drug use for COVID-19 associated with increased risk of cardiac arrhythmias

Research reveals mechanism underlying Parkinson's dyskinesia

Cancer patients with COVID-19 more likely to die from the disease

AHA awards grants to 12 teams for fast-tracked heart and brain health research related to COVID-19

Lipo-ImmunoTech receives grant to develop novel adoptive cell therapy technology for cancer

Study finds Lin28 as promising therapeutic target for central nervous system injuries

Study shows no association between prices and clinical benefit of cancer drugs

Combination of schizophrenia drug and radiation shows promise in treating glioblastoma

Study finds racial differences in time from diagnosis to definitive surgery for melanoma

New math model predicts clinical outcomes in cancer patients treated with immunotherapy

COVID-19 lockdown affecting UK adult mental health

Glasses to stop progression of myopia shown to work in multi-site trial

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News